FLT3 and acute myeloid leukemia: In addition, we transduced FLT3-ITD+ AML cells with vectors expressing DOX-inducible dominant-negative peptides targeting the AP-1 and dnC/EBP TF families followed by a colony assay (Figures S4B and S4C).